Methyldopa is an antihypertensive agent used for the treatment of moderate to severe or malignant hypertension, particularly effective in renal hypertension or hypertension associated with impaired renal function; it is also suitable for secondary hypertension, pregnancy-induced hypertension, hypertension complicated with heart failure or coronary artery disease, and hypertension in elderly patients. L-Methyldopa is a centrally acting alpha-2 adrenergic agonist that lowers blood pressure by stimulating inhibitory alpha-2 receptors in the central nervous system, reducing sympathetic outflow, decreasing plasma renin activity, and lowering peripheral vascular resistance without significantly affecting cardiac output or renal hemodynamics.